InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Jenusaitis Matthew, Director. Officer active across 2 companies, notably Hancock Jaffe Laboratories, Inc.. In total, 6 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €41k. Activity tracked since 25 August 2021. The latest transaction was disclosed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
9,620 shares@ US$2.53100.0% of flowCommon StockSEC:0001493152-24-051172:0
Ideal exit: 15 Sept 2025 (T+270)
1,041 sharesCommon StockSEC:0001493152-22-026070:0
1,042 sharesCommon StockSEC:0001493152-21-022863:0
1,042 sharesCommon StockSEC:0001493152-21-022863
1,300 shares@ US$7.7050.0% of flowCommon Stock, $$0.00001 par valueSEC:0001493152-21-021444:0
Ideal exit: 22 May 2022 (T+270)
1,300 shares@ US$7.7050.0% of flowCommon Stock, $$0.00001 par valueSEC:0001493152-21-021444
Ideal exit: 22 May 2022 (T+270)
6 of 6 declarations
About Jenusaitis Matthew
Jenusaitis Matthew is a Board Member at Hancock Jaffe Laboratories, Inc. He actively participates in strategic decisions and oversight of the company's operations. His experience in the medical sector is an asset for Hancock Jaffe.
